- Market Size (2026)
- USD 510.8 Mn
- Forecast (2036)
- USD 989.0 Mn
- CAGR (2026 to 2036)
- 6.8%
How big is the Acetonitrile Market in 2026?
The global acetonitrile market is estimated at USD 510.8 million in 2026, compared with USD 478.3 million in 2025, and is forecast to reach USD 989.0 million by 2036, expanding at a CAGR of 6.8% from 2026 to 2036.
Specialty grade accounts for 61.3% of the acetonitrile market by product type in 2026. Pharmaceuticals and biotechnology contribute 37.9% by end-user industry while process solvents hold 38.7% by application. These shares indicate that suppliers compete heavily on purity consistency and delivery reliability. Pharmaceutical manufacturers face higher switching costs because changes in analytical solvents may require additional testing and method verification. FMI finds that recent supplier investments address two commercial priorities: improving access to high-purity material and reducing the disruption associated with adopting alternative feedstocks. Buyers are therefore likely to favor suppliers that can demonstrate consistent analytical performance alongside dependable availability. This creates opportunities for producers investing in purification capabilities and documented product quality.
MilliporeSigma launched its bio-based HPLC solvent portfolio on April 21, 2026, offering alternatives compatible with established chromatography methods. The company reported an average 25.9% reduction in carbon dioxide equivalents across the portfolio compared with conventional alternatives. This gives laboratory buyers a measurable sustainability benefit without requiring extensive method redevelopment. Ascend Performance Materials followed a different investment approach by starting its acetonitrile recovery and purification facility at Chocolate Bayou in February 2026. The facility converts material from existing acrylonitrile operations into high-purity solvent suitable for pharmaceutical and analytical customers. This strengthens domestic supply options in the United States while giving Ascend additional commercial value from its existing production operations.

Fresh solvent purchases also depend on how much the customer recovers. Biocon reported that its Malaysian operation reduced fresh acetonitrile consumption by about 140 tons a month in FY2025 through distillation and membrane dehydration. FMI finds that a producer can gain pharmaceutical customers while selling fewer tonnes to an efficient existing account. The separate battery opportunity depends on formulation adoption: Asahi Kasei's August 2026 HighChem Shanghai agreement licenses production and sale of Acetolyte in China rather than reporting a new acetonitrile plant in operation.
Key Market Trends & Insights
- MilliporeSigma reports a 28% lower carbon-dioxide-equivalent impact for its bio-based gradient-grade acetonitrile than its fossil-based counterpart. The comparison is specific to that product; it gives laboratories a sourcing option without establishing a market-wide emissions reduction.
- FDA's FY2025 activities table records 92 first-time generic approvals and 250 tentative approvals. The distinction matters to the pharmaceutical customer pipeline: completed approvals and products still awaiting final approval represent different stages of commercial activity. Neither count is an acetonitrile consumption measure.
- Asahi Kasei reports that EAS Batteries' 22 Ah cell delivered 60% higher specific power under continuous discharge than the comparison cell using conventional electrolyte. The result concerns that cell and test condition; it supports a high-power niche for acetonitrile-containing electrolyte rather than universal battery substitution.
Regional Highlights
- In Latin America, Brazil's July 2026 health-industry framework makes public purchasing and technology-transfer programmes permanent instruments of domestic medicine production. Its insulin-glargine programme includes local active-ingredient capability. FMI sees a more specific potential customer base for process and analytical solvents than a general healthcare-spending pledge, with demand dependent on the processes actually transferred.
- In South Asia and Pacific, Biocon reported that its Malaysian operation avoided about 140 tons a month of fresh acetonitrile consumption in FY2025 through distillation and membrane dehydration. The example shows that regional pharmaceutical expansion and fresh-solvent orders need not move proportionately when an established site improves recovery.
Table 1 Acetonitrile Market Size and Forecast in USD million from 2025 to 2036
| Market size and forecast | Value |
|---|---|
| Market size in 2025 | USD 478.3 million |
| Estimated market size in 2026 | USD 510.8 million |
| Projected market size by 2036 | USD 989.0 million |
| CAGR from 2026 to 2036 | 6.8% |
| Added revenue from 2026 to 2036 | USD 478.2 million |
Source: Future Market Insights, Acetonitrile Market Report, 2026-2036.
Analyst Perspective
“A pharmaceutical plant can increase output and still buy less fresh acetonitrile if it recovers solvent effectively. Suppliers have to earn repeat orders through consistent analytical grade, while battery electrolyte is a separate qualification route.”
- Nikhil Kaitwade, Principal Consultant, FMI
How is the Acetonitrile Market segmented?
- By Product Type: Specialty grade, laboratory grade and industrial grade.
- By End User Industry: Pharmaceuticals and biotechnology segment, chemical industry, laboratories and analytical services, electronics and energy, and others.
- By Application: Process solvent use, Reagent use, Extraction, Chromatography, and Electrochemistry.
- By Region: North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
Why does specialty grade lead by product type?

Specialty grade holds 61.3% of the Acetonitrile Market by product type in 2026, as per FMI's assessment.
Specialty-grade value depends on the analytical performance supplied with the chemical. MilliporeSigma's April 2026 portfolio is designed to preserve established HPLC and LC-MS performance while changing feedstock sourcing. Thermo Fisher's chromatography portfolio separately lists ordinary HPLC acetonitrile, a low-propionitrile product and a gradient-analysis grade meeting the stated pharmacopoeial analytical specification. These distinct offers explain why a single purity percentage or bulk price does not fully describe competition for analytical accounts.
Ascend's new Chocolate Bayou facility recovers material from acrylonitrile operations and purifies it for pharmaceutical and analytical applications. In FMI's reading, the investment expands the supply capable of competing for higher-specification business, while the customer's analytical requirements still determine which finished grade is suitable. Laboratory and industrial grades together retain 38.7% of value; the specialty lead therefore reflects a mix of applications rather than a universal specification for all acetonitrile purchases.
Table 2 Acetonitrile Market Product Type Share Comparison in 2026
| Leading Share | 2026 market share |
|---|---|
| Specialty grade | 61.3% |
| All Other Segments Combined Share | 38.7% |
Source: Future Market Insights, Acetonitrile Market Report, 2026-2036.
Why is the pharmaceuticals and biotechnology segment the largest end user industry category?
The pharmaceuticals and biotechnology segment accounts for 37.9% of the Acetonitrile Market by end user industry in 2026, as per FMI's assessment.
Pharmaceutical manufacturing supports demand across both process and analytical duties. FDA approved 689 abbreviated new drug applications in FY2025, while India's pharmaceutical PLI programme recorded production of 726 APIs, key starting materials and drug intermediates by December 2025. The first is a US regulatory workload and the second an Indian manufacturing measure. Their different scopes support the breadth of the customer base, without providing a solvent-use coefficient or implying that every medicine uses acetonitrile.
Fresh-solvent intensity is a separate influence within that customer base. Biocon's Malaysian programme reduced fresh acetonitrile consumption by about 140 tons a month through recovery. That reported saving restrains merchant orders at the site even when its pharmaceutical operation continues. FMI therefore reads manufacturing activity and solvent recovery together when assessing this end-user group. The chemical industry, independent laboratories, electronics and energy, and other users hold the remaining 62.1%, with different specifications and buying cycles.
Table 3 Acetonitrile Market End User Industry Share Comparison in 2026
| Leading Share | 2026 market share |
|---|---|
| Pharmaceuticals and biotechnology segment | 37.9% |
| All Other Segments Combined Share | 62.1% |
Source: Future Market Insights, Acetonitrile Market Report, 2026-2036.
What supports process solvent use as the leading application?
Process solvent use accounts for 38.7% of the Acetonitrile Market by application in 2026, as per FMI's assessment.
Process solvent use covers production duties that extend across multiple pharmaceutical and chemical products. INEOS identifies acetonitrile as a solvent in insulin and antibiotic production, separately from its role as a raw material in pesticide manufacture. The distinction is commercially relevant: a solvent used during production belongs to this application, while a sale for chemical conversion belongs to reagent use. The breadth of production duties supports the process-solvent category in FMI's assessment without making it a catch-all for every purchase by a pharmaceutical company.
Recovery determines how much of that production requirement reaches the merchant market. Biocon's Malaysian operation reported about 140 tons a month less fresh acetonitrile consumption after distillation and membrane dehydration in FY2025. Production-related solvent circulation can therefore remain substantial as fresh replenishment falls at an individual site. This profile covers reaction media, process operations and cleaning; reagent use, extraction, chromatography and electrochemistry remain separate duties. Their combined 61.3% is the remainder of the application breakdown, with no single rival implied by that total.
Table 4 Acetonitrile Market Application Share Comparison in 2026
| Leading Share | 2026 market share |
|---|---|
| Process solvent use | 38.7% |
| All Other Segments Combined Share | 61.3% |
Source: Future Market Insights, Acetonitrile Market Report, 2026-2036.
What are the key drivers restraints and opportunities?
FMI expects qualified analytical demand, customer recovery and new electrolyte uses to have separate effects on the USD 478.2 million added between 2026 and 2036. More testing supports demand, while a greater recovery rate can reduce the fresh solvent needed for the same output.
Driver
Pharmaceutical production is already expanding at both existing and new sites. India's March 2026 PLI disclosure records INR 41,943 crore invested by December 2025 in brownfield and greenfield projects, alongside 726 APIs, key starting materials and drug intermediates being manufactured. FMI reads this as evidence of a wider operating customer base for process chemicals and analytical supplies. It supports demand development during the forecast period, although the programme's product count is not a measure of acetonitrile use.
Restraint
Recovery reduces fresh merchant requirements where the customer restores used solvent to its process specification. Biocon describes distillation and membrane dehydration at its Malaysian facility, with fresh acetonitrile consumption about 140 tons a month lower in FY2025. The restraint is specific to replenishment at that operation. It gives a concrete reason why pharmaceutical production growth alone would overstate fresh-solvent demand if the forecast ignored changes in recovery.
Opportunity
High-power batteries create an additional outlet where electrolyte performance can justify application development. Asahi Kasei's Acetolyte contains acetonitrile, and EAS Batteries commercialised a cell incorporating it in March 2026. FMI finds that the opportunity is to qualify solvent within a specific formulation and cell design. HighChem Shanghai's non-exclusive Chinese licence provides another commercial route, but neither agreement establishes the volume of solvent that future customers will buy.
How do trade and quality rules affect acetonitrile purchasing?
ICH Q3C R9 makes residual-solvent control a defined constraint in pharmaceutical manufacturing. It places acetonitrile in Class 2, with a permitted daily exposure of 4.1 mg and an Option 1 concentration limit of 410 ppm. These provisions apply to residual solvent in pharmaceuticals within the guideline's scope. They are separate from the purchased solvent's grade specification. FMI finds that pharmaceutical output and incoming-solvent purity alone are insufficient indicators of purchasing requirements because the finished drug must meet the applicable residual-solvent control.
Indian trade conditions have also changed the competitive position of domestic material. Alkyl Amines' FY2026 discussion reports that imports declined and its domestic acetonitrile share improved in the fourth quarter, after imports continued through the third quarter despite the June 2025 anti-dumping levy. This is a company account of the Indian market. It supports an improvement in the local supply position late in the year, without establishing permanent pricing power or a global change in solvent origin.
What limits reliable acetonitrile delivery?
Some acetonitrile supply depends on the operation of an upstream acrylonitrile plant. INEOS describes recovery of acetonitrile made as a co-product during propylene ammoxidation and its subsequent proprietary purification. The constraint therefore includes both availability of the co-product stream and treatment into saleable grades. FMI finds that purification capacity can change the amount reaching high-purity customers even when the upstream route is unchanged.
Ascend's Chocolate Bayou startup adds that recovery and purification stage alongside its acrylonitrile operations. Biocon's customer-side combination of distillation and membrane dehydration illustrates a different part of the chain: restoring spent solvent at a pharmaceutical site. The two investments have different effects on merchant supply. Ascend adds a domestic finished-solvent route, while Biocon's reported saving reduces the fresh replenishment required at its Malaysian operation.
Where can suppliers win additional acetonitrile business?
The analytical sourcing opportunity is to replace fossil-based material within established methods while preserving performance. MilliporeSigma's April 2026 launch expressly targets that position in HPLC and LC-MS. FMI sees the commercial opening in an alternative feedstock for an existing analytical grade, rather than an assumption that customers will change their testing methods. Its product-specific carbon comparison gives that offer a documented sourcing attribute alongside analytical performance.
China provides a separate route through electrolyte licensing. HighChem Shanghai's non-exclusive agreement covers local production and sale of the acetonitrile-containing Acetolyte formulation. This puts an additional application within reach of a company already serving battery manufacturers, with solvent orders dependent on formulation sales and cell adoption. The acetonitrile market captures the chemical purchased for that activity; complete electrolyte, licensing and battery-cell revenue remain outside its value boundary.
Acetonitrile Market by Country (2026 to 2036)
Table 5 Acetonitrile Market Country Growth Forecast from 2026 to 2036

| Country | CAGR |
|---|---|
| Brazil | 7.6% |
| India | 7.6% |
| China | 7.2% |
| United States | 6.4% |
| Germany | 5.8% |
Source: Future Market Insights, Acetonitrile Market Report, 2026-2036.
What supports acetonitrile demand in Brazil?
Brazil is using the purchasing power of its public health system to deepen domestic pharmaceutical production. The Ministry of Health's July 2026 framework establishes a permanent policy for the health economic-industrial complex. It makes technology-transfer partnerships, support for local development and innovation, and technological commissioning continuing instruments of that policy. Productive Development Partnerships connect private participants and public laboratories to build local manufacturing capability. The commercial relevance to acetonitrile is the transfer of production and analytical work into domestic facilities, rather than public health spending alone.
The Ministry identifies insulin glargine among the partnerships, covering capability to produce the active pharmaceutical ingredient and expand local manufacture of the finished product. INEOS separately identifies insulin and antibiotic production as solvent applications for acetonitrile. That provides a specific technical connection to part of the programme, although the Ministry's announcement does not identify solvent contracts, plant consumption or a commissioning date for every project. Vaccine and device programmes in the same framework cannot all be treated as equivalent acetonitrile customers.
FMI forecasts a 7.6% CAGR for Brazil's acetonitrile market from 2026 to 2036 as domestic manufacturing and analytical activity develop. The policy's different instruments imply different timing: technology transfer builds production capability, while technological commissioning finances research with the possibility of later public contracting. This makes the location and progress of manufacturing work more informative for the demand outlook than the law's enactment date or a count of all supported health technologies.
What supports acetonitrile demand in India?
Indian acetonitrile producers enter the forecast period with a changed competitive position against imports. Alkyl Amines reported that imports declined and its domestic share improved in the final quarter of FY2026, after continued imports through the third quarter despite the June 2025 anti-dumping levy. The delayed response matters commercially: a trade measure did not immediately remove competing inventory or deliveries. The company's improvement late in the year supports a stronger domestic position while leaving customers able to compare local and imported material.
Demand-side investment is also visible. By December 2025, cumulative investment under the pharmaceutical PLI scheme had reached INR 41,943 crore in brownfield and greenfield projects. The Department of Pharmaceuticals recorded 1,988 manufactured products under that scheme, including 726 APIs, key starting materials and drug intermediates. Of those 726, 191 were being manufactured in India for the first time. This is a diverse manufacturing base, not a declaration that every supported product consumes acetonitrile.
The same disclosure distinguishes the pharmaceutical programme from the separate bulk-drug scheme, under which manufacturing capacity had been created for 28 critical products by December 2025. FMI reads the two programmes as evidence of production at different stages of the drug chain. Process-solvent demand depends on the chemistry used, while analytical purchases depend on the testing performed; programme expenditure cannot be converted directly into solvent sales.
These operating and investment conditions underpin FMI's 7.6% CAGR forecast for India's acetonitrile market from 2026 to 2036. Domestic producers have both a broader pharmaceutical account base and a reported improvement against import competition. Customer recovery remains a separate influence on fresh orders, so increased medicine output need not produce an equal increase in purchased acetonitrile.
What supports acetonitrile demand in China?
China's new electrolyte route is being developed through a local licensee rather than a newly announced acetonitrile plant. Asahi Kasei's August 2026 non-exclusive agreement allows HighChem Shanghai to produce and sell the acetonitrile-containing Acetolyte formulation in China. HighChem Shanghai is affiliated with a group whose Chinese battery business extends back nearly 20 years, according to the announcement. The agreement places the technology within an existing customer network, giving its introduction a defined commercial channel while leaving adoption by individual battery manufacturers to follow.
FMI's 7.2% CAGR forecast for China's acetonitrile market from 2026 to 2036 includes this application route alongside pharmaceutical and analytical demand. Asahi Kasei attributes the formulation's performance to high ionic conductivity and highlights low-temperature power output and durability at high temperatures. Those attributes identify the applications the licensee is pursuing. They do not establish a solvent requirement across the full electric-vehicle or stationary-storage market, nor do they show that every prospective cell customer has accepted the formulation.
Non-exclusivity also affects the competitive structure. HighChem Shanghai receives a route to local production and sales without sole rights to the Chinese market. In FMI's view, this preserves room for other licensing or supply relationships as the application develops. Formulation adoption is the commercial step between the licence and additional chemical demand, with orders dependent on battery manufacturers incorporating the electrolyte into production. Complete electrolyte sales and licence income remain outside the acetonitrile market total.
What supports acetonitrile demand in the United States?
US pharmaceutical activity gives analytical-solvent suppliers an extensive operating customer base. FDA recorded 689 abbreviated new drug application approvals in FY2025, including 92 first-time generics. Those figures describe regulatory activity across the generic-drug programme. FMI's 6.4% CAGR forecast for the United States acetonitrile market from 2026 to 2036 also reflects changes in available high-purity supply, rather than treating the approval count as a direct solvent-demand multiplier.
Ascend's February 2026 Chocolate Bayou startup recovers acetonitrile produced alongside acrylonitrile and refines it for pharmaceutical manufacturing, analytical laboratories and other specialty applications. Ascend presents domestic recovery as a reduction in import reliance. In FMI's view, this changes supply geography for high-purity customers while retaining dependence on acrylonitrile operations for the raw stream.
MilliporeSigma's April 2026 launch changes another part of the offer: renewable feedstock for products designed to preserve existing HPLC and LC-MS performance. This creates a sourcing alternative within established analytical work. The supplier's lower-carbon comparison applies to the specified product, while the solvent's suitability remains tied to its analytical grade.
Together, domestic purification and alternative analytical feedstock broaden the supply choices serving US demand. They have different effects from customer-side recovery, which reduces fresh replenishment when spent solvent returns to the process. FMI therefore separates growth in qualified analytical purchasing from changes in fresh-solvent intensity at manufacturing accounts. Neither a new drug approval nor a new purification unit alone describes the full national demand outlook.
What supports acetonitrile demand in Germany?
Germany's electrolyte opportunity has moved beyond a licence to a commercially available cell. EAS Batteries launched its Acetolyte-containing cylindrical LFP cell in March 2026 following the November 2025 agreement with Asahi Kasei. In its June announcement, the company reported a nominal 22 Ah capacity, continuous-discharge specific power of 2,550 W/kg and customer sample evaluation. This is an identifiable product outlet for acetonitrile-containing electrolyte, with the commercial scale still dependent on the programmes that adopt it.
The companies also agreed to sublicense their combined technologies to OEMs and battery manufacturers. Their additional 46xxx format remained in development and testing, with a 2026 launch targeted in the June announcement. FMI's 5.8% CAGR forecast for Germany's acetonitrile market from 2026 to 2036 considers these application routes alongside established analytical demand. The commercial cell and the prototype format are at different stages; a target date for the latter does not make it another operating source of solvent demand.
Germany also has an announced expansion of European acetonitrile supply. INEOS announced its intention in April 2022 to invest in a 15 ktpa acetonitrile facility at Köln, intended to serve its European customers. FMI keeps the proposed solvent capacity separate from EAS' actual commercial cell and the 46xxx development programme. Germany's outlook consequently includes both existing analytical purchasing and the extension of electrolyte technology, while preserving the different evidence for available chemical supply, commercial products and prospective applications.
Who are the notable companies in the Acetonitrile Market?
Ascend Performance Materials, Merck KGaA through MilliporeSigma, INEOS Nitriles and Asahi Kasei occupy different positions in the acetonitrile chain. Ascend's February 2026 investment is a recovery and purification facility. Merck's April launch concerns analytical solvent products compatible with established methods. INEOS describes integrated co-product recovery and purification. Asahi Kasei develops and licenses an acetonitrile-containing electrolyte. These are commercial roles rather than interchangeable measures of market leadership.

The disclosed investments address different parts of the same supply chain. Ascend adds a purification outlet for its co-product stream, while MilliporeSigma's launch changes the feedstock of an analytical product designed for existing methods. FMI sees competition in the treatment and specification of the delivered solvent as well as the availability of upstream material. The customer's purchase may pass through both a producer and an analytical supplier, so adding their corporate revenues would double-count business and include unrelated products.
Alkyl Amines adds an Indian manufacturing position shaped by import competition. Its FY2026 discussion reports an improved domestic acetonitrile position late in the year. Balaji Amines also lists acetonitrile in its Indian manufacturing portfolio. Solstice offers LC-MS and HPLC acetonitrile, while Thermo Fisher's Optima portfolio serves analytical laboratories. These additional suppliers give customers alternatives within the relevant grade and supply route. Battery licensing opens another route, but a licence fee or complete-cell sale is distinct from acetonitrile sales and should not be counted as solvent revenue.
Key Developments in the Acetonitrile Market
- In February 2026, Ascend Performance Materials started its acetonitrile recovery and purification facility at Chocolate Bayou for high-purity applications.
- In April 2026, MilliporeSigma introduced its bio-based HPLC solvent portfolio, including acetonitrile designed for established chromatography methods.
- In August 2026, Asahi Kasei concluded a non-exclusive licence with HighChem Shanghai for production and sale of Acetolyte in China.
Key Players in the Acetonitrile Market
- INEOS Nitriles
- Ascend Performance Materials
- Merck KGaA and MilliporeSigma
- Solstice Advanced Materials
- Thermo Fisher Scientific
- Asahi Kasei
- Balaji Amines
- Alkyl Amines Chemicals
Acetonitrile Market Report Scope
Table 6 Report Scope for the Acetonitrile Market
| Coverage field | Report scope |
|---|---|
| Market definition | Commercial acetonitrile supplied for pharmaceutical, analytical, chemical, electronics and energy uses. |
| Revenue boundary | Acetonitrile sales; finished medicines, complete electrolyte formulations, licence fees and battery cells are excluded. |
| Quantitative units | USD million for market value; percentage shares and forecast CAGRs. |
| Forecast period | 2026 to 2036, with 2025 as the preceding reference year. |
| Product types | Specialty grade, laboratory grade and industrial grade. |
| End user industries and application duties | Pharmaceuticals and biotechnology segment, chemical industry, laboratories and analytical services, electronics and energy, and others. Application duties: Process solvent use, Reagent use, Extraction, Chromatography, and Electrochemistry. |
| Global coverage | Seven regions with the nested country and subregion coverage listed below. |
| Detailed country profiles | Brazil, India, China, United States and Germany. |
| Commercial coverage | Qualified grades, recovery, upstream supply, method compatibility and electrolyte application development. |
| Competitive coverage | Producer, analytical-supplier and application-technology roles supported by named corporate disclosures. |
Acetonitrile Market Research Methodology
The report reviews company announcements and annual-report material, pharmaceutical regulatory statistics, the Brazilian health-industry framework, India's pharmaceutical PLI disclosure and ICH residual-solvent guidance. FMI's market values and country forecasts are assessed alongside this secondary evidence. Source dates, geography and announced versus operating status are checked before drawing a commercial implication. Recovery at a single site is kept separate from global demand, and downstream medicine, electrolyte and cell revenues are excluded from the solvent boundary. Application findings distinguish the principal process duty from the delivered grade and the customer industry.
Acetonitrile Market by Segments
Acetonitrile Market segmented by Product Type:
- Specialty grade
- Laboratory grade
- Industrial grade
Acetonitrile Market segmented by End User Industry:
- Pharmaceuticals and biotechnology segment
- Chemical industry
- Laboratories and analytical services
- Electronics and energy
- Others
Acetonitrile Market segmented by Application:
- Process solvent use
- Reagent use
- Extraction
- Chromatography
- Electrochemistry
Acetonitrile Market by Region
- North America
- United States
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Western Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Nordics
- Eastern Europe
- Poland
- Czech Republic
- Romania
- Hungary
- East Asia
- China
- Japan
- South Korea
- Taiwan
- South Asia and Pacific
- India
- Singapore
- Other ASEAN countries
- Australia and New Zealand
- Middle East and Africa
- GCC Countries
- South Africa
- Türkiye
- Israel
Research Sources and Bibliography
- [1] MilliporeSigma. MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography. 21 April 2026.
- [2] Ascend Performance Materials. Ascend cuts ribbon on new high-purity acetonitrile production. 4 February 2026.
- [3] Biocon. Integrated Annual Report FY 2025, Natural Capital, page 143. 2025.
- [4] Asahi Kasei. Asahi Kasei Enters First License Agreement for Production and Sale of Acetolyte Novel Electrolyte in China. 6 August 2026.
- [5] Asahi Kasei. EAS Batteries Starts Sales of Ultra-High-Power Cell Using Asahi Kasei's Novel Electrolyte Acetolyte. 2 June 2026.
- [6] Ministry of Health, Brazil. Lei institui Estratégia Nacional de Saúde do Complexo Econômico-Industrial da Saúde. 20 July 2026.
- [7] Department of Pharmaceuticals, Government of India. Production Linked Incentive Scheme. 20 March 2026.
- [8] US Food and Drug Administration. Generic Drugs Program Activities Report FY 2025 Monthly Performance, approvals table. Accessed 31 October 2026.
- [9] European Medicines Agency. ICH Q3C R9 Guideline on impurities: guideline for residual solvents, Step 5. April 2024.
- [10] Alkyl Amines Chemicals. Annual Report 2025-2026, management discussion and analysis. 2026.
- [11] INEOS Nitriles. INEOS Nitriles to invest in new world scale Acetonitrile plant at its Köln facility to meet European demand. 7 April 2022.
- [12] INEOS Nitriles. Speciality Nitriles, Acetonitrile. Accessed 31 October 2026.
- [13] Solstice Advanced Materials. Acetonitrile LC015, B&J Brand LC-MS product page. Accessed 31 October 2026.
- [14] Thermo Fisher Scientific. Optima LC/MS solvents, chromatography portfolio brochure. Accessed 31 October 2026.
- [15] Balaji Amines. About Us, Annual Report 2026. Accessed 31 October 2026.
Table of Content
- Key Takeaways
- Market Size and CAGR
- Top Growth Driver
- Fastest Growing Segment
- Leading Region
- Key Companies
- Emerging Opportunities
- Executive Summary
- Global Market Outlook
- Demand-side Trends
- Supply-side Trends
- Technology Roadmap Analysis
- Analysis and Recommendations
- Analyst Perspective (What is happening? Why now? What should investors know?)
- Key Questions Answered
- How large is the market?
- What is the CAGR?
- What are key trends?
- Which region dominates?
- Who are the leaders?
Read More...
- Market Overview
- Market Coverage / Taxonomy
- Market Definition / Scope / Limitations
- Research Methodology
- Chapter Orientation
- Analytical Lens and Working Hypotheses
- Market Structure, Signals, and Trend Drivers
- Benchmarking and Cross-market Comparability
- Market Sizing, Forecasting, and Opportunity Mapping
- Research Design and Evidence Framework
- Desk Research Programme (Secondary Evidence)
- Expert Input and Fieldwork (Primary Evidence)
- Tooling, Models, and Reference Databases
- Data Engineering and Model Build
- Quality Assurance and Audit Trail
- Market Background
- Market Dynamics (Drivers, Restraints, Opportunity, Trends)
- Scenario Forecast (Optimistic, Likely, Conservative)
- Impact Analysis
- AI Impact
- Sustainability Impact
- Regulatory Impact
- Technology Impact
- Consumer / Buyer Analysis
- Purchase Drivers
- Adoption Barriers
- Buyer Journey
- Opportunity Map Analysis
- Product Life Cycle Analysis
- Supply Chain Analysis
- Investment Feasibility Matrix
- Value Chain Analysis
- PESTLE and Porter's Analysis
- Regulatory Landscape
- Regional Parent Market Outlook
- Production and Consumption Statistics
- Import and Export Statistics
- Global Market Analysis and Forecast, 2021 to 2036
- Historical Market Size Value (USD Million) Analysis, 2021 to 2025
- Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
- Y-o-Y Growth Trend Analysis
- Absolute $ Opportunity Analysis
- Global Market Pricing Analysis, 2021 to 2036
- Global Market Analysis and Forecast, By Product Type, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Product Type, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Product Type, 2026 to 2036
- Specialty grade
- Laboratory grade
- Industrial grade
- Y-o-Y Growth Trend Analysis By Product Type, 2021 to 2025
- Absolute $ Opportunity Analysis By Product Type, 2026 to 2036
- Global Market Analysis and Forecast, By End User Industry, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By End User Industry, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By End User Industry, 2026 to 2036
- Pharmaceuticals and biotechnology segment
- Chemical industry
- Laboratories and analytical services
- Electronics and energy
- Others
- Y-o-Y Growth Trend Analysis By End User Industry, 2021 to 2025
- Absolute $ Opportunity Analysis By End User Industry, 2026 to 2036
- Global Market Analysis and Forecast, By Application, 2021 to 2036
- Introduction / Key Findings
- Historical Market Size Value (USD Million) Analysis By Application, 2021 to 2025
- Current and Future Market Size Value (USD Million) Analysis and Forecast By Application, 2026 to 2036
- Process solvent use
- Reagent use
- Extraction
- Chromatography
- Electrochemistry
- Y-o-Y Growth Trend Analysis By Application, 2021 to 2025
- Absolute $ Opportunity Analysis By Application, 2026 to 2036
- Global Market Analysis and Forecast, By Region, 2021 to 2036
- Introduction
- Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
- Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia and Pacific
- Middle East and Africa
- Market Attractiveness Analysis By Region
- North America Market Analysis and Forecast, By Country, 2021 to 2036
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- United States
- Canada
- By Product Type
- By End User Industry
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By End User Industry
- By Application
- Key Takeaways
- Latin America Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Brazil
- Mexico
- Argentina
- Chile
- By Product Type
- By End User Industry
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By End User Industry
- By Application
- Key Takeaways
- Western Europe Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Germany
- France
- United Kingdom
- Italy
- Spain
- Benelux
- Nordics
- By Product Type
- By End User Industry
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By End User Industry
- By Application
- Key Takeaways
- Eastern Europe Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- Poland
- Czech Republic
- Romania
- Hungary
- By Product Type
- By End User Industry
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By End User Industry
- By Application
- Key Takeaways
- East Asia Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- China
- Japan
- South Korea
- Taiwan
- By Product Type
- By End User Industry
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By End User Industry
- By Application
- Key Takeaways
- South Asia and Pacific Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- India
- Singapore
- Other ASEAN countries
- Australia and New Zealand
- By Product Type
- By End User Industry
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By End User Industry
- By Application
- Key Takeaways
- Middle East and Africa Market Analysis and Forecast, By Country
- Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
- Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
- By Country
- GCC Countries
- South Africa
- Türkiye
- Israel
- By Product Type
- By End User Industry
- By Application
- By Country
- Market Attractiveness Analysis
- By Country
- By Product Type
- By End User Industry
- By Application
- Key Takeaways
- Key Countries Market Analysis
- United States
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Canada
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Mexico
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Brazil
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Chile
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Germany
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- United Kingdom
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Italy
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Spain
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- France
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- India
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Australia and New Zealand
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- China
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Japan
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- South Korea
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Poland
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Hungary
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- Türkiye
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- South Africa
- Pricing Analysis
- Market Share Analysis, 2025
- By Product Type
- By End User Industry
- By Application
- United States
- Market Structure Analysis
- Competition Dashboard
- Competition Benchmarking
- Market Share Analysis of Top Players
- By Regional
- By Product Type
- By End User Industry
- By Application
- Emerging Startups
- Innovation Benchmarking
- Competition Analysis
- Competition Deep Dive
- Ascend Performance Materials
- Overview
- Product Portfolio
- Profitability by Market Segments
- Sales Footprint
- Strategy Overview
- Marketing Strategy
- Product Strategy
- Channel Strategy
- Merck KGaA and MilliporeSigma
- Asahi Kasei
- INEOS Nitriles
- Solstice Advanced Materials
- Thermo Fisher Scientific
- Balaji Amines
- Alkyl Amines Chemicals
- Ascend Performance Materials
- Case Studies
- Success Stories
- Recent Developments
- Competition Deep Dive
- Assumptions & Acronyms Used
List of Tables
- Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
- Table 2: Global Market Value (USD Million) Forecast by Product Type, 2021 to 2036
- Table 3: Global Market Value (USD Million) Forecast by End User Industry, 2021 to 2036
- Table 4: Global Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 5: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 6: North America Market Value (USD Million) Forecast by Product Type, 2021 to 2036
- Table 7: North America Market Value (USD Million) Forecast by End User Industry, 2021 to 2036
- Table 8: North America Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 9: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 10: Latin America Market Value (USD Million) Forecast by Product Type, 2021 to 2036
- Table 11: Latin America Market Value (USD Million) Forecast by End User Industry, 2021 to 2036
- Table 12: Latin America Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 13: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 14: Western Europe Market Value (USD Million) Forecast by Product Type, 2021 to 2036
- Table 15: Western Europe Market Value (USD Million) Forecast by End User Industry, 2021 to 2036
- Table 16: Western Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 17: Eastern Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 18: Eastern Europe Market Value (USD Million) Forecast by Product Type, 2021 to 2036
- Table 19: Eastern Europe Market Value (USD Million) Forecast by End User Industry, 2021 to 2036
- Table 20: Eastern Europe Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 21: East Asia Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 22: East Asia Market Value (USD Million) Forecast by Product Type, 2021 to 2036
- Table 23: East Asia Market Value (USD Million) Forecast by End User Industry, 2021 to 2036
- Table 24: East Asia Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 25: South Asia and Pacific Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 26: South Asia and Pacific Market Value (USD Million) Forecast by Product Type, 2021 to 2036
- Table 27: South Asia and Pacific Market Value (USD Million) Forecast by End User Industry, 2021 to 2036
- Table 28: South Asia and Pacific Market Value (USD Million) Forecast by Application, 2021 to 2036
- Table 29: Middle East and Africa Market Value (USD Million) Forecast by Country, 2021 to 2036
- Table 30: Middle East and Africa Market Value (USD Million) Forecast by Product Type, 2021 to 2036
- Table 31: Middle East and Africa Market Value (USD Million) Forecast by End User Industry, 2021 to 2036
- Table 32: Middle East and Africa Market Value (USD Million) Forecast by Application, 2021 to 2036
List of Figures
- Figure 1: Global Market Pricing Analysis
- Figure 2: Global Market Value (USD Million) Forecast 2021-2036
- Figure 3: Global Market Value Share and BPS Analysis by Product Type, 2026 and 2036
- Figure 4: Global Market Y-o-Y Growth Comparison by Product Type, 2026-2036
- Figure 5: Global Market Attractiveness Analysis by Product Type
- Figure 6: Global Market Value Share and BPS Analysis by End User Industry, 2026 and 2036
- Figure 7: Global Market Y-o-Y Growth Comparison by End User Industry, 2026-2036
- Figure 8: Global Market Attractiveness Analysis by End User Industry
- Figure 9: Global Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 10: Global Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 11: Global Market Attractiveness Analysis by Application
- Figure 12: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
- Figure 13: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
- Figure 14: Global Market Attractiveness Analysis by Region
- Figure 15: North America Market Incremental Dollar Opportunity, 2026-2036
- Figure 16: Latin America Market Incremental Dollar Opportunity, 2026-2036
- Figure 17: Western Europe Market Incremental Dollar Opportunity, 2026-2036
- Figure 18: Eastern Europe Market Incremental Dollar Opportunity, 2026-2036
- Figure 19: East Asia Market Incremental Dollar Opportunity, 2026-2036
- Figure 20: South Asia and Pacific Market Incremental Dollar Opportunity, 2026-2036
- Figure 21: Middle East and Africa Market Incremental Dollar Opportunity, 2026-2036
- Figure 22: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 23: North America Market Value Share and BPS Analysis by Product Type, 2026 and 2036
- Figure 24: North America Market Y-o-Y Growth Comparison by Product Type, 2026-2036
- Figure 25: North America Market Attractiveness Analysis by Product Type
- Figure 26: North America Market Value Share and BPS Analysis by End User Industry, 2026 and 2036
- Figure 27: North America Market Y-o-Y Growth Comparison by End User Industry, 2026-2036
- Figure 28: North America Market Attractiveness Analysis by End User Industry
- Figure 29: North America Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 30: North America Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 31: North America Market Attractiveness Analysis by Application
- Figure 32: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 33: Latin America Market Value Share and BPS Analysis by Product Type, 2026 and 2036
- Figure 34: Latin America Market Y-o-Y Growth Comparison by Product Type, 2026-2036
- Figure 35: Latin America Market Attractiveness Analysis by Product Type
- Figure 36: Latin America Market Value Share and BPS Analysis by End User Industry, 2026 and 2036
- Figure 37: Latin America Market Y-o-Y Growth Comparison by End User Industry, 2026-2036
- Figure 38: Latin America Market Attractiveness Analysis by End User Industry
- Figure 39: Latin America Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 40: Latin America Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 41: Latin America Market Attractiveness Analysis by Application
- Figure 42: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 43: Western Europe Market Value Share and BPS Analysis by Product Type, 2026 and 2036
- Figure 44: Western Europe Market Y-o-Y Growth Comparison by Product Type, 2026-2036
- Figure 45: Western Europe Market Attractiveness Analysis by Product Type
- Figure 46: Western Europe Market Value Share and BPS Analysis by End User Industry, 2026 and 2036
- Figure 47: Western Europe Market Y-o-Y Growth Comparison by End User Industry, 2026-2036
- Figure 48: Western Europe Market Attractiveness Analysis by End User Industry
- Figure 49: Western Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 50: Western Europe Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 51: Western Europe Market Attractiveness Analysis by Application
- Figure 52: Eastern Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 53: Eastern Europe Market Value Share and BPS Analysis by Product Type, 2026 and 2036
- Figure 54: Eastern Europe Market Y-o-Y Growth Comparison by Product Type, 2026-2036
- Figure 55: Eastern Europe Market Attractiveness Analysis by Product Type
- Figure 56: Eastern Europe Market Value Share and BPS Analysis by End User Industry, 2026 and 2036
- Figure 57: Eastern Europe Market Y-o-Y Growth Comparison by End User Industry, 2026-2036
- Figure 58: Eastern Europe Market Attractiveness Analysis by End User Industry
- Figure 59: Eastern Europe Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 60: Eastern Europe Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 61: Eastern Europe Market Attractiveness Analysis by Application
- Figure 62: East Asia Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 63: East Asia Market Value Share and BPS Analysis by Product Type, 2026 and 2036
- Figure 64: East Asia Market Y-o-Y Growth Comparison by Product Type, 2026-2036
- Figure 65: East Asia Market Attractiveness Analysis by Product Type
- Figure 66: East Asia Market Value Share and BPS Analysis by End User Industry, 2026 and 2036
- Figure 67: East Asia Market Y-o-Y Growth Comparison by End User Industry, 2026-2036
- Figure 68: East Asia Market Attractiveness Analysis by End User Industry
- Figure 69: East Asia Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 70: East Asia Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 71: East Asia Market Attractiveness Analysis by Application
- Figure 72: South Asia and Pacific Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 73: South Asia and Pacific Market Value Share and BPS Analysis by Product Type, 2026 and 2036
- Figure 74: South Asia and Pacific Market Y-o-Y Growth Comparison by Product Type, 2026-2036
- Figure 75: South Asia and Pacific Market Attractiveness Analysis by Product Type
- Figure 76: South Asia and Pacific Market Value Share and BPS Analysis by End User Industry, 2026 and 2036
- Figure 77: South Asia and Pacific Market Y-o-Y Growth Comparison by End User Industry, 2026-2036
- Figure 78: South Asia and Pacific Market Attractiveness Analysis by End User Industry
- Figure 79: South Asia and Pacific Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 80: South Asia and Pacific Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 81: South Asia and Pacific Market Attractiveness Analysis by Application
- Figure 82: Middle East and Africa Market Value Share and BPS Analysis by Country, 2026 and 2036
- Figure 83: Middle East and Africa Market Value Share and BPS Analysis by Product Type, 2026 and 2036
- Figure 84: Middle East and Africa Market Y-o-Y Growth Comparison by Product Type, 2026-2036
- Figure 85: Middle East and Africa Market Attractiveness Analysis by Product Type
- Figure 86: Middle East and Africa Market Value Share and BPS Analysis by End User Industry, 2026 and 2036
- Figure 87: Middle East and Africa Market Y-o-Y Growth Comparison by End User Industry, 2026-2036
- Figure 88: Middle East and Africa Market Attractiveness Analysis by End User Industry
- Figure 89: Middle East and Africa Market Value Share and BPS Analysis by Application, 2026 and 2036
- Figure 90: Middle East and Africa Market Y-o-Y Growth Comparison by Application, 2026-2036
- Figure 91: Middle East and Africa Market Attractiveness Analysis by Application
- Figure 92: Global Market - Tier Structure Analysis
- Figure 93: Global Market - Company Share Analysis
Frequently Asked Questions
What is the Acetonitrile Market forecast?
FMI estimates USD 510.8 million in 2026, compared with USD 478.3 million in 2025, and forecasts USD 989.0 million in 2036 at a 6.8% CAGR.
Which product type leads the Acetonitrile Market?
Specialty grade holds 61.3% of 2026 value by product type in FMI's assessment.
Which end user industry and application lead the Acetonitrile Market?
The pharmaceuticals and biotechnology segment accounts for 37.9% by end user industry, while process solvent use holds 38.7% by application in 2026, in FMI's assessment.
Which profiled countries have the highest growth?
Brazil and India share the highest forecast CAGR at 7.6% from 2026 to 2036, followed by China at 7.2%, the United States at 6.4% and Germany at 5.8%.
How does recovery affect fresh acetonitrile orders?
Recovered solvent can replace fresh replenishment at a customer site. Biocon reported about 140 tons a month less fresh consumption at its Malaysian facility in FY2025; that result is specific to the site. [3]
Preview the report firsthand - request a free sample
Get SampleGet the brochure for pricing and purchase details.
Get PDF